SoundSelf provides an immersive, voice‑activated biofeedback platform that creates personalized soundscapes responsive to a user’s breath and physiological signals.
Funding
Funding not disclosed
Founders
Product
Problem
Therapists and patients often lack accessible, engaging tools to prepare for and integrate non‑ordinary states of consciousness induced by psychedelic or psycho‑spiritual interventions, leading to suboptimal therapeutic outcomes and limited patient engagement.
Solution
SoundSelf offers an immersive, voice‑activated biofeedback platform that guides users through deep, somatically engaging sound experiences. Real‑time physiological feedback helps clients cultivate attention, embodied creativity, and mindfulness, which are linked to better treatment results. The system can be used before, during, and after sessions with ketamine, psilocybin, MDMA, plant medicines, or other transformative practices, enhancing preparation, reducing anxiety, and supporting integration of insights. Therapists can incorporate the technology into their workflow to increase patient engagement, train skills predictive of clinical improvement, and provide a non‑drug psychedelic experience that broadens accessibility to advanced mental‑health interventions.
Target Audience
Primary customers are mental‑health clinicians—such as psychiatrists, psychologists, licensed counselors, and psychedelic‑therapy providers—who seek tools to enhance patient preparation, engagement, and integration during advanced therapeutic interventions.
Features
- Voice‑controlled soundscape that adapts to the user’s breath and physiological signals, creating a personalized immersive experience
- Real‑time biofeedback loop (e.g., heart‑rate, breathing) that trains attention and mindfulness skills
- Structured sessions for pre‑treatment preparation, intra‑session support, and post‑treatment integration
- Clinician dashboard with session metrics and progress tracking to inform therapeutic decisions
- Compatibility with a range of psychedelic and psycho‑spiritual protocols, including ketamine, psilocybin, MDMA, and plant‑medicine therapies
- Designed for use in clinical settings or remotely, supporting tele‑therapy and hybrid care models